Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio)

The introduction of Cystic Fibrosis Trans Regulatory modulator (CFTRm) drugs has seen a transformation in Cystic Fibrosis (CF) treatment. This has led to a significant improvement in lung function and quality of life with the potential for a real impact on life expectancy. Transient mild to moderate...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehi, Mahan, Iqbal, Mubashar, Dube, Asha, AlJoudeh, Amer, Edenborough, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593462/
https://www.ncbi.nlm.nih.gov/pubmed/34815934
http://dx.doi.org/10.1016/j.rmcr.2021.101553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593462/
https://www.ncbi.nlm.nih.gov/pubmed/34815934
http://dx.doi.org/10.1016/j.rmcr.2021.101553

Ejemplares similares